Related Experiment Videos
A model of the platelet factor 4 complex with heparin
J A Stuckey1, R St Charles, B F Edwards
1Department of Biochemistry, Wayne State University School of Medicine, Detroit, Michigan 48201.
Proteins
|October 1, 1992
Summary
A structural model reveals how heparin binds to bovine platelet factor 4 (BPF4). Heparin
Area of Science:
- Biochemistry
- Structural Biology
- Molecular Modeling
Background:
- Bovine platelet factor 4 (BPF4) is a protein involved in blood clotting and inflammation.
- Heparin is a glycosaminoglycan anticoagulant that interacts with various proteins, including PF4.
- Understanding the structural basis of heparin-BPF4 interaction is crucial for drug development and biological studies.
Purpose of the Study:
- To develop a detailed structural model of heparin bound to bovine platelet factor 4 (BPF4).
- To elucidate the specific binding interactions and electrostatic complementarity between heparin and BPF4.
- To investigate the role of key residues, such as lysines and His-38, in heparin binding.
Main Methods:
- Graphical modeling of a heparin molecule using established chemical representations.
- Utilizing crystallographic coordinates of the native bovine platelet factor 4 tetramer (2.6 Å resolution, R=0.237).
- Performing electrostatic calculations on the BPF4 tetramer to identify charged regions.
Main Results:
- A model was generated showing heparin (≥8 disaccharide units, highly sulfated) bound to the BPF4 tetramer.
- BPF4 monomers feature an alpha-helix with solvent-accessible lysines, forming a positive charge ring across the tetramer.
- The model positions heparin perpendicularly to the alpha-helices, interacting electrostatically with the positive charge ring and salt-linking to lysines.
Conclusions:
- The study provides a detailed structural model for heparin-BPF4 complex formation.
- Heparin binding is mediated by electrostatic interactions along a positively charged ring on the BPF4 tetramer.
- Key lysine residues on the alpha-helix and His-38 are critical for high-affinity heparin binding.